• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于iTRAQ的难治性肺炎支原体肺炎患者定量蛋白质组学研究

iTRAQ-based Quantitative Proteomics Study in Patients with Refractory Mycoplasma pneumoniae Pneumonia.

作者信息

Yu Jia-Lu, Song Qi-Fang, Xie Zhi-Wei, Jiang Wen-Hui, Chen Jia-Hui, Fan Hui-Feng, Xie Ya-Ping, Lu Gen

机构信息

Guangzhou Women and Children's Medical Center, Guangzhou Medical University.

Department of Bioengineering, Guangdong Province Key Laboratory of Molecular Immunology and Antibody Engineering, Jinan University.

出版信息

Jpn J Infect Dis. 2017 Sep 25;70(5):571-578. doi: 10.7883/yoken.JJID.2016.355. Epub 2016 Dec 22.

DOI:10.7883/yoken.JJID.2016.355
PMID:28003598
Abstract

Mycoplasma pneumoniae (MP) is a leading cause of community-acquired pneumonia in children and young adults. Although MP pneumonia is usually benign and self-limited, in some cases it can develop into life-threating refractory MP pneumonia (RMPP). However, the pathogenesis of RMPP is poorly understood. The identification and characterization of proteins related to RMPP could provide a proof of principle to facilitate appropriate diagnostic and therapeutic strategies for treating paients with MP. In this study, we used a quantitative proteomic technique (iTRAQ) to analyze MP-related proteins in serum samples from 5 patients with RMPP, 5 patients with non-refractory MP pneumonia (NRMPP), and 5 healthy children. Functional classification, sub-cellular localization, and protein interaction network analysis were carried out based on protein annotation through evolutionary relationship (PANTHER) and Cytoscape analysis. A total of 260 differentially expressed proteins were identified in the RMPP and NRMPP groups. Compared to the control group, the NRMPP and RMPP groups showed 134 (70 up-regulated and 64 down-regulated) and 126 (63 up-regulated and 63 down-regulated) differentially expressed proteins, respectively. The complex functional classification and protein interaction network of the identified proteins reflected the complex pathogenesis of RMPP. Our study provides the first comprehensive proteome map of RMPP-related proteins from MP pneumonia. These profiles may be useful as part of a diagnostic panel, and the identified proteins provide new insights into the pathological mechanisms underlying RMPP.

摘要

肺炎支原体(MP)是儿童和青年社区获得性肺炎的主要病因。尽管MP肺炎通常为良性且具有自限性,但在某些情况下可发展为危及生命的难治性MP肺炎(RMPP)。然而,RMPP的发病机制尚不清楚。鉴定和表征与RMPP相关的蛋白质可为制定针对MP肺炎患者的适当诊断和治疗策略提供原理证明。在本研究中,我们使用定量蛋白质组学技术(iTRAQ)分析了5例RMPP患者、5例非难治性MP肺炎(NRMPP)患者和5名健康儿童血清样本中的MP相关蛋白质。基于通过进化关系进行蛋白质注释(PANTHER)和Cytoscape分析,进行了功能分类、亚细胞定位和蛋白质相互作用网络分析。在RMPP组和NRMPP组中总共鉴定出260种差异表达蛋白质。与对照组相比,NRMPP组和RMPP组分别显示出134种(70种上调和64种下调)和126种(63种上调和63种下调)差异表达蛋白质。所鉴定蛋白质的复杂功能分类和蛋白质相互作用网络反映了RMPP的复杂发病机制。我们的研究提供了首个来自MP肺炎的RMPP相关蛋白质的综合蛋白质组图谱。这些图谱可能作为诊断指标的一部分有用,并且所鉴定的蛋白质为RMPP潜在的病理机制提供了新见解。

相似文献

1
iTRAQ-based Quantitative Proteomics Study in Patients with Refractory Mycoplasma pneumoniae Pneumonia.基于iTRAQ的难治性肺炎支原体肺炎患者定量蛋白质组学研究
Jpn J Infect Dis. 2017 Sep 25;70(5):571-578. doi: 10.7883/yoken.JJID.2016.355. Epub 2016 Dec 22.
2
Ribosomal RNA‑depleted RNA sequencing reveals the pathogenesis of refractory pneumonia in children.核糖体 RNA depleted RNA 测序揭示儿童难治性肺炎的发病机制。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12401. Epub 2021 Sep 3.
3
High expression of HMGB1 in children with refractory Mycoplasma pneumoniae pneumonia.HMGB1 在难治性肺炎支原体肺炎患儿中的高表达。
BMC Infect Dis. 2018 Aug 29;18(1):439. doi: 10.1186/s12879-018-3346-8.
4
Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children.儿童难治性肺炎支原体肺炎的临床和实验室特征
Int J Infect Dis. 2014 Dec;29:18-23. doi: 10.1016/j.ijid.2014.07.020. Epub 2014 Oct 22.
5
Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children.难治性肺炎支原体肺炎患儿中趋化因子谱的改变。
J Microbiol Immunol Infect. 2021 Aug;54(4):673-679. doi: 10.1016/j.jmii.2020.03.030. Epub 2020 Apr 8.
6
[Correlation between galectin-3 level in bronchoalveolar lavage fluid and cellular immunity in children with refractory Mycoplasma pneumoniae pneumonia].[难治性支原体肺炎患儿支气管肺泡灌洗液中半乳糖凝集素-3水平与细胞免疫的相关性]
Zhongguo Dang Dai Er Ke Za Zhi. 2019 Feb;21(2):150-154. doi: 10.7499/j.issn.1008-8830.2019.02.008.
7
High co-expression of TNF-α and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia.TNF-α 和 CARDS 毒素的高共表达是难治性肺炎支原体肺炎的良好预测指标。
Mol Med. 2019 Aug 9;25(1):38. doi: 10.1186/s10020-019-0105-2.
8
[Clinical report on 68 cases of refractory mycoplasma pneumoniae pneumonia (RMPP)].68例难治性支原体肺炎(RMPP)临床报告
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Jun;25(3):224-6.
9
The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children.儿童中糖皮质激素耐药性难治性肺炎支原体肺炎的临床特征。
Sci Rep. 2016 Dec 23;6:39929. doi: 10.1038/srep39929.
10
[Early identification of refractory Mycoplasma pneumoniae pneumonia in children].[儿童难治性肺炎支原体肺炎的早期识别]
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Nov;17(11):1189-92.

引用本文的文献

1
Recent Macrolide Resistance Pattern of Mycoplasma Pneumonia in the World: A Systematic Review and Meta-Analysis.全球肺炎支原体近期的大环内酯类耐药模式:一项系统评价与Meta分析
Iran J Public Health. 2025 Mar;54(3):530-541. doi: 10.18502/ijph.v54i3.18246.
2
Application of Protein Expression in Study.蛋白质表达在研究中的应用。
Scientifica (Cairo). 2024 Oct 14;2024:4142663. doi: 10.1155/2024/4142663. eCollection 2024.
3
Clinical efficacy of macrolide antibiotics in mycoplasma pneumoniae pneumonia carrying a macrolide-resistant mutation in the 23 S rRNA gene in pediatric patients.
大环内酯类抗生素对23S rRNA基因携带大环内酯类耐药突变的小儿支原体肺炎的临床疗效
BMC Infect Dis. 2024 Jul 31;24(1):758. doi: 10.1186/s12879-024-09612-6.
4
Update on the Epidemiology of Macrolide-Resistant in Europe: A Systematic Review.欧洲大环内酯类耐药流行病学最新情况:一项系统评价
Infect Dis Rep. 2021 Sep 2;13(3):811-820. doi: 10.3390/idr13030073.
5
Emergent Pneumonia in Children.儿童急性肺炎
Front Pediatr. 2021 Jun 17;9:676296. doi: 10.3389/fped.2021.676296. eCollection 2021.
6
Chinese Herbal Medicine for the Treatment of Children and Adolescents With Refractory Pneumonia: A Systematic Review and a Meta-Analysis.中药治疗儿童及青少年难治性肺炎的系统评价与Meta分析
Front Pharmacol. 2021 Jun 10;12:678631. doi: 10.3389/fphar.2021.678631. eCollection 2021.
7
Clinical characteristics of refractory mycoplasma pneumoniae pneumonia in children treated with glucocorticoid pulse therapy.糖皮质激素脉冲疗法治疗儿童难治性肺炎支原体肺炎的临床特征。
BMC Infect Dis. 2021 Jan 28;21(1):126. doi: 10.1186/s12879-021-05830-4.
8
Pathogenic Analysis of the Bronchoalveolar Lavage Fluid Samples With Pediatric Refractory Pneumonia.儿童难治性肺炎支气管肺泡灌洗液样本的病原学分析。
Front Cell Infect Microbiol. 2020 Oct 28;10:553739. doi: 10.3389/fcimb.2020.553739. eCollection 2020.
9
Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.病毒混合感染和大环内酯类耐药支原体感染对难治性肺炎支原体肺炎患儿的影响。
BMC Infect Dis. 2020 Aug 26;20(1):633. doi: 10.1186/s12879-020-05356-1.
10
Low Bacterial Co-infection Invalidates the Early Use of Non-anti- Antibiotics in Pediatric Refractory Pneumonia Patients.低细菌合并感染使小儿难治性肺炎患者早期使用非抗抗生素无效。
Front Pediatr. 2018 Oct 26;6:296. doi: 10.3389/fped.2018.00296. eCollection 2018.